Apteka na Zawadzie Spółka z Ograniczoną Odpowiedzialnością (KRS 0000479216, NIP 5783113070) is a Polish company, headquartered in Łódź, Łódzkie voivodeship. APTEKA NA ZAWADZIE operates in: Dispensing chemist in specialised stores (PKD 47.73.Z). Industry: Retail trade. The company has been listed in the National Court Register since October 2, 2013. APTEKA NA ZAWADZIE's most recently reported net revenue was 9.3 M PLN for 2024.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Apteka na Zawadzie
Identity
- Name
- Apteka na Zawadzie Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- October 2, 2013
- Registry status as of
- April 23, 2026
- Latest entry
- April 23, 2026
- Founding act
- AKT NOTARIALNY Z DNIA 31.05.2013 R., REP. A NR 1656/2013, NOTARIUSZ MARZENA PONIATOWSKA, KANCELARIA NOTARIALNA W ELBLĄGU…
Articles of association history (3)
- May 31, 2013: AKT NOTARIALNY Z DNIA 31.05.2013 R., REP. A NR 1656/2013, NOTARIUSZ MARZENA PONIATOWSKA, KANCELARIA NOTARIALNA W ELBLĄGU.
- May 23, 2014: 23.05.2014R. ASESOR NOTARIALNY BARTŁOMIEJ JANICKI-ZACTĘPCA NOTARIUSZA PIOTRA KRÓLA, KANCELARIA NOTARIALNA W ŁODZI, REP.A NR 1509/2014 - ZMIENIONO § 3, § 4 UST.2, § 6, § 9 UST.2, § 11 UST.3, § 14-16, § 17, § 18, § 19-22, USUNIĘTO § 10 UST.4, § 11 UST.2, § 13
- 20 SIERPNIA 2025 R., REP. A NR 3466/2025, NOTARIUSZ BARTŁOMIEJ JANICKI, KANCELARIA NOTARIALNA W ALEKSANDROWIE ŁÓDZKIM, PRZYJĘCIE NOWEGO BRZMIENIA UMOWY SPÓŁKI.
Activities
Main activity
47.73.ZDispensing chemist in specialised stores
Other activities
Address and contact
- Address
- KINGA C. GILETTE, 11, 94-406, ŁÓDŹ, POLSKA
- Voivodeship
- ŁÓDZKIE
- District
- M. ŁÓDŹ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-46501-10482-CWHIB-26
Risk and payment profile - Apteka na Zawadzie
Credibility rating
77.3 / 100
Good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/13 yrs
Board changes
2
2/13 yrs
PKD changes
3
3/13 yrs
Name changes
0
0/13 yrs
Data from 13 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: B (77/100)
Trend: stable (+0.4 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Trade credit limit history
Standard limit from 2018–2024
Current: 811.0 K PLN
Safe: 395.4 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Apteka na Zawadzie
Founded
October 2, 2013
12 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
ŁÓDŹ
ŁÓDZKIE
Primary PKD
47.73.Z
Dispensing chemist in specialised stores
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
3 people
Filed years
7 years
2018–2024
Registry entries
34
latest: April 23, 2026
Revenue
9.3 M PLN
2024
Net profit
632.2 K PLN
2024
Assets
3.0 M PLN
2024
Equity
1.2 M PLN
2024
EBITDA
704.8 K PLN
2024
Valuation
4.1 M PLN
High confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Apteka na Zawadzie.
No ratings
Related articles
News
Ambra in 2026: PLN 48.1 m capex (+212%), PLN 1.10 dividend three years running, Cydr Lubelski plus Romanian Zarea as the premium engine
Warsaw-based Ambra S.A. (KRS 0000041726, ul. Puławska 336) closed H1 of fiscal 2025/2026 with PLN 556.8 m of revenue and PLN 49.0 m of net profit, while raising capex by 212% to PLN 48.1 m - mainly for the soft-drinks line in Wola Duża and the PLN 11.9 m acquisition of a Romanian company. Despite the aggressive investment cycle the board keeps a PLN 1.10 dividend per share for the third year running (~5.9% yield).
News
Answear in 2026: first full year without MCI, PLN 9.3 m net profit, but the supervisory board cuts the 2026 EBITDA target from PLN 100 m to PLN 90 m
Kraków-based Answear.com S.A. (KRS 0000816066) closed 2025 with revenue of PLN 1.7 bn (+13% YoY), EBITDA of PLN 56 m (+63%) and net profit of PLN 9.3 m - a return to the black after a PLN 10 m loss in 2024. Poland grew +31%, but CEE was under FX pressure (hryvnia -11% vs PLN), and a weak Q4 (EBITDA -71% YoY) forced the supervisory board to cut the 2026 EBITDA target from PLN 100 m to PLN 90 m and the target price from PLN 50 to PLN 45. It is the first full year after MCI's exit from the shareholder base (10 June 2025); the Bajołek brothers retain control (57.8%).
